生物谷 >> Drug discovery

· Special topics

· Recommended News

NoEliteInfo

·Drug discoveryInfoList

[FDA files]Astellas Educates and Informs Physicians and Patients on Cha	佚名	02-03
[FDA files]FDA Statement on Fraudulent, Unapproved Influenza-Related Pr	佚名	02-03
[FDA files]Nuvelo Receives FDA Fast Track Status for Alfimeprase	佚名	02-03
[FDA files]Biogen Idec and Elan Announce Notification of FDA Advisory C	佚名	02-03
[FDA files]FDA Joint Advisory Committee Recommends Approval of Orlistat	佚名	02-03
[FDA files]CepTor Receives Dual Orphan Drug Designation for Myodur (C10	佚名	02-03
[FDA files]BioMarin Receives FDA Fast Track Designation for Phenoptin f	佚名	02-03
[FDA files]FDA Grants Discovery Labs Surfaxin Fast Track Designation fo	佚名	02-03
[FDA files]Boston Scientific Announces Two Communications From FDA	佚名	02-03
[FDA files]Orphan Drug Designation Granted by European Commission for A	佚名	02-03
[FDA files]FDA Announces Atazanavir Labeling Changes	佚名	02-03
[FDA files]Schering-Plough Reports FDA Grants Fast Track Designation to	佚名	02-03
[FDA files]TheraQuest Receives 7-Year Market Exclusivity for Topical Ca	佚名	02-03
[FDA files]ActivBiotics Receives FDA Fast Track Status for Rifalazil in	佚名	02-03
[FDA files]Nabi Biopharmaceuticals Announces U.S. Fast Track Designatio	佚名	02-03
[FDA files]FDA Grants Fast Track Designation for the Investigation of Z	佚名	02-03
[Drug news]DOR BioPharma Announces Positive Phase I Results of RiVax, i	佚名	02-03
[Drug news]Potential new use in osteoporosis adds value to Metabolic’s	佚名	02-03
[Drug news]Study Results Indicate the CYPHER Sirolimus-Eluting Coronary	佚名	02-03
[Drug news]Lorus Announces the Presentation of Virulizin Phase III Clin	佚名	02-03

共 147 articleInfo 首页上一页下一页尾页页次：2/8页 20articleInfo/页转到：

· Hot News

Brazil advised to

China-Europe team